Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Computerized Drug Warning Alerts Remain Largely Ignored

By HospiMedica International staff writers
Posted on 19 Apr 2012
A new study finds that 96% of computerized drug warning alerts generated in hospitals are overridden out of hand. More...


Researchers at the Johns Hopkins Bayview Medical Center (Baltimore, MD, USA) examined data from the 410-bed academic medical center to clarify the factors associated with accepting or overriding a warning from the hospital computerized provider order entry (CPOE) system, developed to generate warnings when there is the possibility of allergy, adverse events, interactions, and duplications, with the intent of increasing inpatient safety. To do so, they identified 6,646 patients - mean age 57, 44% male, with a mean length of hospital stay of four days. When differentiated, 45% were on medical wards, 29% in psychiatric departments, 28% on surgical wards, , and small numbers in other departments such as obstetrics and gynecology.

The researchers found that for the patients whose medication orders generated at least a single warning, the median range of medications per patient was four. The reasons for the warnings were duplications in 47%, potential interactions in 47%, allergies in 6%, and only 0.1% for potential adverse reactions. One-quarter of the warnings were for parenteral medications, and 13% were on the list of high-alert medications. While only 4% of the warnings for oral medications were accepted, warnings for parenteral medications were accepted twice as often, at 8%. The study was presented at the Society of Hospital Medicine (SHM) annual meeting, held during April 2012 in San Diego (CA, USA).

“The least common warnings were those that were most frequently accepted, with the average accepted warnings for drug interactions and allergy being 37% and 10%, respectively,” said lead author and study presenter Amy Knight, MD. “The problem with these computerized warning systems is that providers develop 'alert fatigue' and end up overriding many potentially important warnings.”

“Developers of these computerized provider systems need to revise their programs to more clearly differentiate between types of warnings and, in particular, to distinguish the warnings that are most likely to have severe consequences,” concluded Dr. Knight.

Related Links:

Johns Hopkins Bayview Medical Center



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.